Stocks hit 52-week lows despite positive results
Several stocks, including NextNav, Mesoblast, Plug Power, Mineralys, and Syndax, hit 52-week lows despite some reporting strong revenue or positive analyst outlooks.
NextNav Inc.’s stock hit a 52-week low at $10.06, falling 19.2% over the past year and 50% in the last six months, despite exceeding revenue expectations and becoming debt-free. Mesoblast Ltd ADR reached a 52-week low of $13.03, down 23.26% year-over-year, but reported 599% revenue growth and its first full year of commercial sales. Plug Power Inc. dropped to a 52-week low of $1.40, reflecting a 58.38% annual decline, though it recently beat expectations and secured new supply agreements. Mineralys Therapeutics closed at a 52-week low of $20.40, down 52.71% year-over-year, with a wider-than-expected loss due to increased spending ahead of a drug launch. Syndax Pharmaceuticals touched a 52-week low at $12.98, down 8.53% for the year, after halting a clinical trial, though analysts remain positive on other drug prospects.